AI Article Synopsis

  • Lung adenocarcinoma (LUAD) is linked to high mortality rates, and the protein S100A16 is suggested to have prognostic importance in this cancer, although its exact mechanism is unclear.
  • The study analyzed S100A16 expression in LUAD tissues and cells, revealing that higher levels of S100A16 correlate with poorer patient outcomes and that reducing S100A16 decreases cell growth, migration, invasion, and angiogenesis.
  • It was found that S100A16 interacts with the MOV10 protein, stabilizes ITGA3 mRNA, and affects ECM-receptor interactions, ultimately enhancing the aggressive characteristics of LUAD.

Article Abstract

Lung adenocarcinoma (LUAD) is highly associated with lung cancer‑associated mortality. Notably, S100 calcium‑binding protein A16 (S100A16) has been increasingly considered to have prognostic value in LUAD; however, the underlying mechanism remains unknown. In the present study, S100A16 expression levels in LUAD tissues and cells were respectively analyzed by the UALCAN database and western blotting. Cell Counting Kit‑8 and 5‑ethynyl‑2'‑deoxyuridine assays were used to examine cell proliferation, whereas wound healing, Transwell and tube formation assays were used to assess cell migration, invasion and angiogenesis, respectively. Western blotting was also used to examine the expression levels of proteins associated with metastasis, angiogenesis, focal adhesion and the extracellular matrix (ECM)‑receptor interaction pathways. The relationship between S100A16 and Mov10 RNA helicase (MOV10) was predicted by bioinformatics tools, and was verified using a co‑immunoprecipitation assay. Furthermore, the interaction between MOV10 and integrin α3 (ITGA3) was verified by RNA immunoprecipitation assay, and the actinomycin D assay was used to detect ITGA3 mRNA stability. The results demonstrated that S100A16 expression was increased in LUAD tissues and cell lines, and was associated with unfavorable outcomes. Knocking down S100A16 expression hindered the proliferation, migration, invasion and angiogenesis of LUAD cells. Furthermore, S100A16 was shown to bind to MOV10 and positively modulate MOV10 expression in LUAD cells, while MOV10 overexpression partially reversed the suppressive role of S100A16 knockdown on the aggressive phenotypes of LUAD cells. Furthermore, it was demonstrated that S100A16 regulated the stability of ITGA3 mRNA via MOV10 to mediate ECM‑receptor interactions. In conclusion, S100A16 may bind to MOV10 to stabilize ITGA3 mRNA and regulate ECM‑receptor interactions, hence contributing to the malignant progression of LUAD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541165PMC
http://dx.doi.org/10.3892/mmr.2024.13376DOI Listing

Publication Analysis

Top Keywords

s100a16 expression
12
itga3 mrna
12
luad cells
12
s100a16
10
mov10
9
ecm‑receptor interaction
8
lung adenocarcinoma
8
luad
8
expression levels
8
luad tissues
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!